May 01,2022

Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study

‘Healthier You’, the National Health Service (NHS) diabetes prevention programme (DPP) offers adults in England at high risk of type 2 diabetes (T2DM) an evidence-based behavioral intervention to prevent or delay T2DM onset. This study assesses the impact of a pilot digital stream of the DPP (DDPP) on glycated hemoglobin (HbA1c) and weight.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
May 02,2022

Beta Bionics says iLet bionic pancreas reduces HbA1c and improves time in range for T1D

Beta Bionics announced positive results from a pivotal trial of its iLet bionic pancreas for the delivery of insulin in diabetes patients. Beta Bionics designed the pocket-sized, wearable, investigational iLet device to autonomously dose insulin. Worn like an insulin pump, iLet users only enter bodyweight to initialize therapy without the need for insulin regimen parameters.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
May 02,2022

ASCENSIA DIABETES CARE PRESENTS NEW RESEARCH SHOWING THAT PEOPLE USING THE CONTOUR® BLOOD GLUCOSE MONITORING SYSTEM AND APP EXPERIENCE FEWER OUT-OF-TARGET BLOOD GLUCOSE LEVELS

Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributor of the Eversense® continuous glucose monitoring (CGM) system, announces a new study demonstrating that people who use the connected CONTOUR® BGM systems (BGMS) and CONTOUR®DIABETES App (CDA) for at least six months can see a reduced frequency of hypoglycaemic and hyperglycaemic blood glucose readings (BGRs).

CLINICAL STUDY

#bgm

View Analyst & Ambassador Comments
Go to original news
May 03,2022

CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022

All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out.

#cgm

#insulin pump

#insulin pen

View Analyst & Ambassador Comments
Go to original news
May 03,2022

Evaluating Factors Associated With Continuous Glucose Monitoring Utilization With the Type 1 Diabetes Exchange Registry

This study evaluates socioeconomic and demographic metrics associated with CGM use.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
May 03,2022

One Drop Recognized by Fast Company in 2022 World Changing Ideas Awards

AI-enabled CVD prevention program delivered through One Drop's digital health platform appears in the Apps category of Fast Company’s 2022 World Changing Ideas List.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 04,2022

DarioHealth to Report First Quarter 2022 Results on Thursday, May 12

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on Thursday, May 12, 2022.

View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick Health grabs $55M for digital-first care programs

Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 04,2022

Brighter Reports First Quarter 2022 Financial Report

Brighter AB [publ], today published the first quarter interim report for January – March 2022.

View Analyst & Ambassador Comments
Go to original news
May 04,2022

Jade Diabetes makes Diabetes Simpler with Alexa Insulin Dosing

Jade Diabetes releases world first voice-based insulin dosing for diabetes that turns the labor-intensive task of logging blood sugars, carbohydrates, insulin and exercise into a natural conversation.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES